AI-ECG Tracker vs Viz HCM
AI Verdict
Choose AI-ECG Tracker if…
Choose AI-ECG Tracker if your organization requires a comprehensive and highly accurate AI solution for the auto-diagnosis of a wide array of cardiac abnormalities from 12-lead ECG data. This tool is ideal for institutions seeking rapid, on-premise processing with optional cloud services to support a broad spectrum of ECG diagnostic classifications, ensuring efficient and detailed analysis across many cardiac conditions.
View AI-ECG Tracker →Choose Viz HCM if…
Choose Viz HCM if your primary focus is on improving the early detection, diagnosis, and coordinated care pathways specifically for Hypertrophic Cardiomyopathy (HCM). This cloud-based AI tool excels at real-time ECG analysis for suspected HCM, providing mobile alerts and automating patient direction to specialists, thereby streamlining workflows and reducing time to treatment for this particular condition.
View Viz HCM →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-ECG Tracker | Viz HCM |
|---|---|---|
| Deployment | Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities. | Unknown |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz HCMViz HCM (Tool B) offers a cloud-based platform with seamless integration into existing EHR and PACS systems, alongside mobile-based alerts for multidisciplinary care teams. This approach prioritizes streamlined clinical workflows and accessibility. AI-ECG Tracker (Tool A), while offering a web-based management portal, relies on an on-premise workstation and a Windows-based client, which may present more friction in modern, integrated healthcare environments.
Clinical Value
Viz HCMWhile AI-ECG Tracker (Tool A) boasts high accuracy across a broad range of cardiac abnormalities, Viz HCM (Tool B) demonstrates a more focused and concretely validated clinical value for Hypertrophic Cardiomyopathy (HCM). Viz HCM is FDA-cleared, clinically validated with extensive real-world evidence, and significantly reduces diagnosis time for HCM, with CMS reimbursement available for specific CPT codes. This combination of targeted impact, strong validation, and financial benefit gives Tool B an edge.
Pricing & Value
Viz HCMViz HCM (Tool B) provides a clear pricing structure as subscription-based for hospitals and health systems, with the added benefit of CMS reimbursement for specific CPT codes, which directly contributes to its value proposition. AI-ECG Tracker (Tool A) does not publicly disclose its pricing, making it impossible to assess its value without direct vendor engagement. The transparency and potential for reimbursement make Tool B a more attractive option in terms of pricing and value.
Enterprise Readiness
Viz HCMViz HCM (Tool B) explicitly states 'yes' for both BAA and HIPAA compliance, and emphasizes seamless integration with existing EHR and PACS systems, which are crucial for enterprise adoption. AI-ECG Tracker (Tool A)'s BAA and HIPAA compliance are described as 'likely' but not explicitly confirmed for the product, and its on-premise components might introduce more integration complexities compared to a fully cloud-native, integrated solution like Tool B.
Innovation
Viz HCMBoth tools utilize AI for ECG analysis, but Viz HCM (Tool B) extends its innovation beyond mere diagnosis to intelligent care coordination. It offers real-time disease detection for HCM, coupled with mobile-based alerts and automated patient direction to specialists, actively streamlining clinical workflows. AI-ECG Tracker (Tool A) focuses on broad, accurate, and rapid auto-diagnosis, which is innovative, but Viz HCM's integration of care coordination represents a more advanced application of AI in the healthcare ecosystem.
Support & Docs
Viz HCMViz HCM (Tool B) offers a comprehensive support infrastructure, including a dedicated Knowledge Base, Help Center, customer resources, user guides, and 24/7 urgent phone and email support. Their Trust Center also provides direct access to security and privacy documentation. In contrast, specific details regarding product-level support and documentation for AI-ECG Tracker (Tool A) are not readily available in the provided information or public searches, making Tool B's offerings significantly more transparent and robust.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-ECG Tracker | Viz HCM |
|---|---|---|
| Company | Shenzhen Carewell Electronics Co. | Viz.ai |
| Primary AI Detection Focus | Common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction (16 cardiac classifications and 104 ECG diagnostic classifications) | Suspected Hypertrophic Cardiomyopathy (HCM) |
| Stated Accuracy | High accuracy (over 95%) for common cardiac abnormalities | Not specified |
| Diagnosis Speed | Rapid diagnosis in approximately 3 seconds | Reduces time to diagnosis and treatment for HCM |
| Care Coordination Features | Not specified | Mobile-based alerts and notifications to multidisciplinary care teams; Automated direction of patients to appropriate care specialists; Streamlines cardiac care coordination and clinical workflows |
Videos
Demos, reviews, and walkthroughs featuring AI-ECG Tracker and Viz HCM.